Medical Innovation Exchange

MedTech Economics

Protecting Innovation in FemTech

Protecting Innovation in FemTech     As opportunities for innovation and investment in women’s healthcare accelerate, Femtech is helping to match capital and talent to unmet needs[1], enabling better outcomes for female patients and consumers, stakeholders, and society at large.[2] Broadly defined, Femtech provides a wide range of solutions to improve healthcare for women across a …

Protecting Innovation in FemTech Read More »

Assignor Estoppel: Protecting Your Patent Rights

Assignor Estoppel: Protecting Your Patent Rights     The centuries-old common law doctrine of assignor estoppel is intended to prevent an inventor from making inconsistent representations about a patent’s validity by first warranting the patent is valid when assigning rights, but then later claiming the patent is invalid. In 2021, while upholding the doctrine in Hologic …

Assignor Estoppel: Protecting Your Patent Rights Read More »

Harnessing the Potential of LinkedIn for MedTech Professionals

Harnessing the Potential of LinkedIn for MedTech Professionals     At some point since the start of the pandemic, a movement has been underway among seasoned professionals and experts across the life science sector. Sharing their expertise on LinkedIn has become a critical success factor, rather than a distraction. Nonetheless, LinkedIn is still a mystery for …

Harnessing the Potential of LinkedIn for MedTech Professionals Read More »

Cleeland Joins Francis Medical Board of Directors

Cleeland Joins Francis Medical Board of Directors     Andrew Cleeland, CEO of Fogarty Innovations, has joined the Francis Medical Board of Directors. Francis Medical is a privately held medical device company developing a proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer. Prior to joining Fogarty Innovations, Cleeland served as …

Cleeland Joins Francis Medical Board of Directors Read More »

Liver-Chip Successfully Identifies Drug Toxicity, Outperforms Animal and 3D Models

Liver-Chip Successfully Identifies Drug Toxicity, Outperforms Animal and 3D Models     Organ-on-chip technology can outperform animal models and could generate billions in increased R&D productivity, according to the outcomes of a study published in Communications Medicine (December 2022). For “Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology,” Lorna Ewert, et al, …

Liver-Chip Successfully Identifies Drug Toxicity, Outperforms Animal and 3D Models Read More »

WHO Convenes Panel to Identify Priority Pathogens for Research and Oversight 

WHO Convenes Panel to Identify Priority Pathogens for Research and Oversight      The World Health Organization (WHO) announced that it is launching a global scientific process to update the list of priority pathogens to guide global investment, research and development of vaccines, tests and treatments. The process began on November 18 with a meeting of …

WHO Convenes Panel to Identify Priority Pathogens for Research and Oversight  Read More »

Pharma Needs a New Class of CRM Solutions

Pharma Needs a New Class of CRM Solutions     Today’s pharma companies face three primary challenges in their efforts to engage with their customers. There are more ways than ever before to engage—and as the response to the pandemic showed, digital engagements play an increasingly vital role. There are more stakeholders to engage than ever …

Pharma Needs a New Class of CRM Solutions Read More »

Johnson & Johnson to Expand Cardiovascular Segment with Abiomed Acquisition

Johnson & Johnson to Expand Cardiovascular Segment with Abiomed Acquisition     Johnson & Johnson has entered into a definitive agreement to acquire Abiomed, developer of breakthrough heart, lung and kidney support technologies, for approximately $16.6 billion. The transaction—expected to be completed prior to the end of the first quarter of 2023—will broaden Johnson & Johnson …

Johnson & Johnson to Expand Cardiovascular Segment with Abiomed Acquisition Read More »

M&As: Maximizing the Partnership Process on Both Sides

M&As: Maximizing the Partnership Process on Both Sides     At the MedExecWomen meeting on June 14, 2022, Leslie Storms, U.S. president of Ethicon, a J&J Division, moderated the panel “Making Acquisition Strategy Succeed: Perspectives From Both Sides Of The Deal” and brought M&A experts Martha Shadan, developer of a novel tissue regeneration technology for shoulder …

M&As: Maximizing the Partnership Process on Both Sides Read More »

Pres. Biden Issues Executive Order on Advancing Biotechnology and Biomanufacturing

Pres. Biden Issues Executive Order on Advancing Biotechnology and Biomanufacturing     On September 12, President Joe Biden issued an executive order, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy.” The order outlines a “whole-of-government approach” to advance biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, …

Pres. Biden Issues Executive Order on Advancing Biotechnology and Biomanufacturing Read More »